FRA:ZEG - Deutsche Boerse Ag - GB0009895292 - Common Stock - Currency: EUR
Overall ZEG gets a fundamental rating of 5 out of 10. We evaluated ZEG against 50 industry peers in the Pharmaceuticals industry. While ZEG has a great profitability rating, there are some minor concerns on its financial health. ZEG has a correct valuation and a medium growth rate.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 7.31% | ||
ROE | 18.94% | ||
ROIC | 14.1% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 24.05% | ||
PM (TTM) | 14.14% | ||
GM | 82.36% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.71 | ||
Debt/FCF | 3.46 | ||
Altman-Z | 4.92 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 0.9 | ||
Quick Ratio | 0.7 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 16.04 | ||
Fwd PE | 13.23 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 47.01 | ||
EV/EBITDA | 22.78 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 2.31% |
FRA:ZEG (7/17/2025, 7:00:00 PM)
119.65
-0.8 (-0.66%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 2.31% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 16.04 | ||
Fwd PE | 13.23 | ||
P/S | 7.81 | ||
P/FCF | 47.01 | ||
P/OCF | 32.82 | ||
P/B | 10.47 | ||
P/tB | N/A | ||
EV/EBITDA | 22.78 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 7.31% | ||
ROE | 18.94% | ||
ROCE | 17.15% | ||
ROIC | 14.1% | ||
ROICexc | 15.14% | ||
ROICexgc | 76.66% | ||
OM | 24.05% | ||
PM (TTM) | 14.14% | ||
GM | 82.36% | ||
FCFM | 16.62% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.71 | ||
Debt/FCF | 3.46 | ||
Debt/EBITDA | 1.47 | ||
Cap/Depr | 58.81% | ||
Cap/Sales | 7.18% | ||
Interest Coverage | 9.49 | ||
Cash Conversion | 65.63% | ||
Profit Quality | 117.58% | ||
Current Ratio | 0.9 | ||
Quick Ratio | 0.7 | ||
Altman-Z | 4.92 |